Compare CRDF & VIRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CRDF | VIRC |
|---|---|---|
| Founded | 1999 | 1950 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Industrial Specialties |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 114.2M | 99.1M |
| IPO Year | 2012 | 1995 |
| Metric | CRDF | VIRC |
|---|---|---|
| Price | $1.21 | $6.23 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 1 |
| Target Price | ★ $9.63 | $7.30 |
| AVG Volume (30 Days) | ★ 1.7M | 45.3K |
| Earning Date | 05-07-2026 | 04-08-2026 |
| Dividend Yield | N/A | ★ 1.65% |
| EPS Growth | ★ 27.37 | N/A |
| EPS | N/A | N/A |
| Revenue | $365,993.00 | ★ $199,652,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $19.77 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 49.61 | N/A |
| 52 Week Low | $1.16 | $5.16 |
| 52 Week High | $4.56 | $9.07 |
| Indicator | CRDF | VIRC |
|---|---|---|
| Relative Strength Index (RSI) | 34.42 | 55.12 |
| Support Level | N/A | $5.99 |
| Resistance Level | $1.72 | $6.44 |
| Average True Range (ATR) | 0.17 | 0.26 |
| MACD | -0.04 | 0.03 |
| Stochastic Oscillator | 7.15 | 67.80 |
Cardiff Oncology Inc is a clinical-stage biotechnology company that leverages PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies for various cancers with unmet medical needs. The company focuses on targeting tumor vulnerabilities with treatment combinations of onvansertib, its oral and selective PLK1 inhibitor, and standard-of-care (SoC) therapeutics. The firm's clinical program pipeline focuses on indications such as RAS-mutated metastatic colorectal cancer (mCRC), investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma (mPDAC), small cell lung cancer (SCLC), metastatic triple negative breast cancer (mTNBC), and Chronic Myelomonocytic Leukemia (CMML). Geographically, it operates only in the United States.
Virco Manufacturing Corp is engaged in designing, production and distributing quality furniture for the commercial and education markets. The company manufactures an assortment of products, including mobile tables, mobile storage equipment, desks, computer furniture, chairs, activity tables, folding chairs, and folding tables. Its primary furniture lines are constructed of tubular metal legs and frames, combined with wood and plastic tops, plastic seats and backs, upholstered seats and backs, and upholstered rigid polyethylene and polypropylene shells.